Independent intelligence on healthtech across Asia and the Middle East
The Future Health Digital Innovation Challenge 2026 competition will focus on fertility, population health and wellbeing, with three finalists sharing a US$105,000 prize pool.
The finalists are Ardens Lifescience of South Korea, BaiYi Healthcare of China, Eyes of AI of Australia, and Physiologas Technologies of Japan.
The 2026 World Bio Summit will bring together government officials, healthcare professionals and industry representatives to discuss the role of AI in healthcare and the biohealth sector.
The initiative aims to bring together germline data relating to inherited genetic variation, tumour sequencing and laboratory research models within a centralised resource.
The report treats the ethics of embodied intelligence as part of broader AI ethics, while identifying risks arising from the direct interaction between intelligent systems, people and their surroundings.
The case highlights the application of robotic-assisted surgery in complex preventive procedures for patients with a high inherited risk of cancer.
M42 said it would demonstrate how its capabilities across clinical care, genomics, biobanking, AI and digital health could support earlier identification of health risks.
An Israeli platform is aiming to close a longstanding gap in how patients report adverse drug reactions, giving them a direct channel to share their experiences.
The Government has positioned new measures within its wider plans to develop Hong Kong as an international health and medical innovation hub.